home / stock / chgcy / chgcy news


CHGCY News and Press, Chugai Pharmaceuticals Co. Ltd. ADR

Stock Information

Company Name: Chugai Pharmaceuticals Co. Ltd. ADR
Stock Symbol: CHGCY
Market: OTC

Menu

CHGCY CHGCY Quote CHGCY Short CHGCY News CHGCY Articles CHGCY Message Board
Get CHGCY Alerts

News, Short Squeeze, Breakout and More Instantly...

CHGCY - Expected US Company Earnings on Thursday, April 25th, 2024

Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...

CHGCY - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Call Transcript

2024-04-24 23:40:02 ET Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Conference Call April 24, 2024 5:00 AM ET Company Participants Kae Miyata - Head of Corporate Communications Osamu Okuda - President and Chief Executive Officer Tsukasa Kusano - Execu...

CHGCY - Argenx gains after setback to Roche/Chugai myasthenia gravis therapy

2024-03-21 07:00:09 ET More on Argenx SE argenx SE (ARGX) Q4 2023 Earnings Call Transcript argenx: Upgrading To 'Strong Buy' On Vyvgart's Q4 Sales, Empasiprubart Data, Pipeline Expansion Argenx SE GAAP EPS of -$1.68 misses by $0.30, revenue of $374M beats by $10.28M ...

CHGCY - Week In Review: LianBio To Close Operations; Will Pay $528M To Shareholders

2024-02-18 02:05:00 ET Summary LianBio plans to stop all its operations by the end of 2024 and will distribute a $4.80 dividend/share ($528M) to its shareholders. Yiviva signed a memorandum of understanding with AstraZeneca China for an R&D collaboration at AstraZeneca’...

CHGCY - Expected US Company Earnings on Thursday, February 1st, 2024

IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2023-10-31 Deluxe Corporation (DLX) is expected to report $0.62 for Q4 2023 SkyWest Inc. (SKYW) is expected to report $0.11 for Q4 2023 1-800-FLOWERS.COM Inc. (FLWS) is expected to report $1.22 for Q2 2024 Brook...

CHGCY - Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B Deal

2023-12-17 02:00:00 ET Summary SystImmune out-licenses global rights for a bispecific ADC to Bristol Myers Squibb in an $8.4 billion agreement. Evive Biotech forms an antibody discovery collaboration with Nona Biosciences to accelerate the process of antibody discovery and drug de...

CHGCY - Expected US Company Earnings on Monday, October 23rd, 2023

Grandsouth Bancorporation (GRRB) is expected to report for quarter end 2023-09-30 Cadence Bank (CADE) is expected to report $0.56 for Q3 2023 Enterprise Financial Services Corporation (EFSC) is expected to report $1.24 for Q3 2023 Blackhawk Bancorp Inc. (BHWB) is expected to report fo...

CHGCY - Expected US Company Earnings on Thursday, September 28th, 2023

Novonix Limited (NVNXF) is expected to report for quarter end 2023-06-30 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Arrival (ARVL) is expected to report for quarter end 2023-06-30 Treasure Global Inc. (TGL) is expected to report $-0.16 for Q4 2023 Manch...

CHGCY - Expected US Company Earnings on Thursday, September 21st, 2023

Aspen Pharmacare Holdings Ltd ADR (APNHY) is expected to report for quarter end 2023-06-30 China Jo-Jo Drugstores Inc. (CJJD) is expected to report for quarter end 2023-06-30 Brewbilt Brewing Co (BRBL) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to ...

CHGCY - Expected US Company Earnings on Thursday, September 14th, 2023

Verbund AG ADR (OEZVY) is expected to report for Q2 2023 Adtran Networks SE (ADVOF) is expected to report for Q2 2023 OMV AG (OMVJF) is expected to report $1.66 for Q2 2023 Firm Capital Property Trust Unit (FRMUF) is expected to report for Q1 2024 Minim Inc (MINM) is expected to r...

Next 10